Concepedia

Lingran Du

LD

Statistics

Publications

12

Citations

517

H-Index

12

Active since

2007

Affiliations

Guangzhou Medical University(Current)

Second Affiliated Hospital of Guangzhou Medical University

State Key Laboratory of Respiratory Disease

Peking University

The First Affiliated Hospital, Sun Yat-sen University

Lingran Du is an author at Guangzhou Medical University specializing in drug delivery, pharmacology, and pharmacy.

Publications per year

2007–2021

12

Publications

12

Aminoglucose-functionalized, redox-responsive polymer nanomicelles for overcoming chemoresistance in lung cancer cells

Yi Zhou, Huaying Wen, Liang Gu et al. · Journal of Nanobiotechnology · 2017 · 105 citations · Full text

, , +17

MiR-142-3p enhances chemosensitivity of breast cancer cells and inhibits autophagy by targeting HMGB1

Lu Liang, Jijun Fu, Siran Wang et al. · Acta Pharmaceutica Sinica B · 2019 · 80 citations · Full text

, , +17

The microneedles carrying cisplatin and IR820 to perform synergistic chemo-photodynamic therapy against breast cancer

Jijun Fu, Chuwen Li, Yang Liu et al. · Journal of Nanobiotechnology · 2020 · 64 citations · Full text

, , +17

Aloperine executes antitumor effects against multiple myeloma through dual apoptotic mechanisms

He Wang, Shu Yang, Hong Zhou et al. · Journal of Hematology & Oncology · 2015 · 57 citations · Full text

, , +17

Folate-mediated mitochondrial targeting with doxorubicin-polyrotaxane nanoparticles overcomes multidrug resistance

He Wang, Heng-hui Yin, Fengjiao Yan et al. · Oncotarget · 2014 · 48 citations · Full text

, , +17

1–5 of 12